A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial

The aim of this report is to introduce an on-going, multicenter, randomized controlled trial to evaluate whether tailored antimicrobial prophylaxis guided by rectal culture screening prevents acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Patients will be randomized into a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta medica Okayama 2021-10, Vol.75 (5), p.663-667
Hauptverfasser: Sadahira, Takuya, Maruyama, Yuki, Hiyama, Yoshiki, Kitano, Hiroyuki, Yamada, Hiroki, Goto, Takayuki, Kondo, Tsubasa, Shigemura, Katsumi, Mitsui, Yosuke, Iwata, Takehiro, Edamura, Kohei, Araki, Motoo, Watanabe, Masami, Takenaka, Tadasu, Teishima, Jun, Miyata, Yasuyoshi, Ishikawa, Kiyohito, Takaoka, Ei-Ichiro, Miyazaki, Jun, Takahashi, Satoshi, Masumori, Naoya, Kiyota, Hiroshi, Fujisawa, Masato, Yamamoto, Shingo, Sakuma, Takafumi, Kusumi, Norihiro, Ichikawa, Takaharu, Watanabe, Toyohiko, Nasu, Yoshitsugu, Tsugawa, Masaya, Nasu, Yasutomo, Wada, Koichiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 667
container_issue 5
container_start_page 663
container_title Acta medica Okayama
container_volume 75
creator Sadahira, Takuya
Maruyama, Yuki
Hiyama, Yoshiki
Kitano, Hiroyuki
Yamada, Hiroki
Goto, Takayuki
Kondo, Tsubasa
Shigemura, Katsumi
Mitsui, Yosuke
Iwata, Takehiro
Edamura, Kohei
Araki, Motoo
Watanabe, Masami
Takenaka, Tadasu
Teishima, Jun
Miyata, Yasuyoshi
Ishikawa, Kiyohito
Takaoka, Ei-Ichiro
Miyazaki, Jun
Takahashi, Satoshi
Masumori, Naoya
Kiyota, Hiroshi
Fujisawa, Masato
Yamamoto, Shingo
Sakuma, Takafumi
Kusumi, Norihiro
Ichikawa, Takaharu
Watanabe, Toyohiko
Nasu, Yoshitsugu
Tsugawa, Masaya
Nasu, Yasutomo
Wada, Koichiro
description The aim of this report is to introduce an on-going, multicenter, randomized controlled trial to evaluate whether tailored antimicrobial prophylaxis guided by rectal culture screening prevents acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Patients will be randomized into an intervention or non-intervention group; tazobactam-piperacillin or levofloxacin will be prophylactically administered according to the results of rectal culture prior to TRPB in the intervention group whereas levofloxacin will be routinely given in the non-intervention group. The primary endpoint is the occurrence rate of acute bacterial prostatitis after TRPB. Recruitment begins in April, 2021 and the target total sample size is 5,100 participants.
doi_str_mv 10.18926/amo/62782
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2586995940</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2586995940</sourcerecordid><originalsourceid>FETCH-LOGICAL-j345t-64710c71983e70c89db4d25ed2d3b03efecca488142d60690ab0e4706da9a0df3</originalsourceid><addsrcrecordid>eNo1kMFO3DAQhn1oBRR66QNUPnJowLETJ-a2XVFaCQSii9TbamJPwMixF9up2D5gn6teCpeZkeb_5h_9hHyq2UndKy5PYQqnknc9f0cOmOhlJRj7tU8-pPTIGG-UZHtkXzQdE6zlB-Tvgi6d9VaDo6toSz3_DW6GbP09zQ9I7xKOs_OYEg0jXYF1IaKhC5_tZHUMw465iWHzsHXwbFMBdugt6gyu0rPLc0T6U0dEv1tcobFQABsizaF4gk_xRby7kjJkpF9t2KTtGV3Qq8JbjT5j_EJvwZsw2T_Ffhl8jsG5Mr58fUTej-ASfnzth-Tu2_lq-b26vL74sVxcVo-iaXMlm65muqtVL7BjuldmaAxv0XAjBiZwRK2h6fu64UYyqRgMDEtW0oACZkZxSI7_393E8DRjyuvJJo3OgccwpzVve6lUqxpWpJ9fpfMwoVlvop0gbtdv2Yt_qUqINA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586995940</pqid></control><display><type>article</type><title>A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial</title><source>MEDLINE</source><source>Open Access Titles of Japan</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sadahira, Takuya ; Maruyama, Yuki ; Hiyama, Yoshiki ; Kitano, Hiroyuki ; Yamada, Hiroki ; Goto, Takayuki ; Kondo, Tsubasa ; Shigemura, Katsumi ; Mitsui, Yosuke ; Iwata, Takehiro ; Edamura, Kohei ; Araki, Motoo ; Watanabe, Masami ; Takenaka, Tadasu ; Teishima, Jun ; Miyata, Yasuyoshi ; Ishikawa, Kiyohito ; Takaoka, Ei-Ichiro ; Miyazaki, Jun ; Takahashi, Satoshi ; Masumori, Naoya ; Kiyota, Hiroshi ; Fujisawa, Masato ; Yamamoto, Shingo ; Sakuma, Takafumi ; Kusumi, Norihiro ; Ichikawa, Takaharu ; Watanabe, Toyohiko ; Nasu, Yoshitsugu ; Tsugawa, Masaya ; Nasu, Yasutomo ; Wada, Koichiro</creator><creatorcontrib>Sadahira, Takuya ; Maruyama, Yuki ; Hiyama, Yoshiki ; Kitano, Hiroyuki ; Yamada, Hiroki ; Goto, Takayuki ; Kondo, Tsubasa ; Shigemura, Katsumi ; Mitsui, Yosuke ; Iwata, Takehiro ; Edamura, Kohei ; Araki, Motoo ; Watanabe, Masami ; Takenaka, Tadasu ; Teishima, Jun ; Miyata, Yasuyoshi ; Ishikawa, Kiyohito ; Takaoka, Ei-Ichiro ; Miyazaki, Jun ; Takahashi, Satoshi ; Masumori, Naoya ; Kiyota, Hiroshi ; Fujisawa, Masato ; Yamamoto, Shingo ; Sakuma, Takafumi ; Kusumi, Norihiro ; Ichikawa, Takaharu ; Watanabe, Toyohiko ; Nasu, Yoshitsugu ; Tsugawa, Masaya ; Nasu, Yasutomo ; Wada, Koichiro</creatorcontrib><description>The aim of this report is to introduce an on-going, multicenter, randomized controlled trial to evaluate whether tailored antimicrobial prophylaxis guided by rectal culture screening prevents acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Patients will be randomized into an intervention or non-intervention group; tazobactam-piperacillin or levofloxacin will be prophylactically administered according to the results of rectal culture prior to TRPB in the intervention group whereas levofloxacin will be routinely given in the non-intervention group. The primary endpoint is the occurrence rate of acute bacterial prostatitis after TRPB. Recruitment begins in April, 2021 and the target total sample size is 5,100 participants.</description><identifier>ISSN: 0386-300X</identifier><identifier>DOI: 10.18926/amo/62782</identifier><identifier>PMID: 34703052</identifier><language>eng</language><publisher>Japan</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Bacterial Infections - diagnosis ; Bacterial Infections - drug therapy ; Bacterial Infections - microbiology ; Humans ; Male ; Multicenter Studies as Topic ; Prostatic Diseases - drug therapy ; Prostatic Diseases - microbiology ; Prostatic Diseases - pathology ; Randomized Controlled Trials as Topic</subject><ispartof>Acta medica Okayama, 2021-10, Vol.75 (5), p.663-667</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34703052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sadahira, Takuya</creatorcontrib><creatorcontrib>Maruyama, Yuki</creatorcontrib><creatorcontrib>Hiyama, Yoshiki</creatorcontrib><creatorcontrib>Kitano, Hiroyuki</creatorcontrib><creatorcontrib>Yamada, Hiroki</creatorcontrib><creatorcontrib>Goto, Takayuki</creatorcontrib><creatorcontrib>Kondo, Tsubasa</creatorcontrib><creatorcontrib>Shigemura, Katsumi</creatorcontrib><creatorcontrib>Mitsui, Yosuke</creatorcontrib><creatorcontrib>Iwata, Takehiro</creatorcontrib><creatorcontrib>Edamura, Kohei</creatorcontrib><creatorcontrib>Araki, Motoo</creatorcontrib><creatorcontrib>Watanabe, Masami</creatorcontrib><creatorcontrib>Takenaka, Tadasu</creatorcontrib><creatorcontrib>Teishima, Jun</creatorcontrib><creatorcontrib>Miyata, Yasuyoshi</creatorcontrib><creatorcontrib>Ishikawa, Kiyohito</creatorcontrib><creatorcontrib>Takaoka, Ei-Ichiro</creatorcontrib><creatorcontrib>Miyazaki, Jun</creatorcontrib><creatorcontrib>Takahashi, Satoshi</creatorcontrib><creatorcontrib>Masumori, Naoya</creatorcontrib><creatorcontrib>Kiyota, Hiroshi</creatorcontrib><creatorcontrib>Fujisawa, Masato</creatorcontrib><creatorcontrib>Yamamoto, Shingo</creatorcontrib><creatorcontrib>Sakuma, Takafumi</creatorcontrib><creatorcontrib>Kusumi, Norihiro</creatorcontrib><creatorcontrib>Ichikawa, Takaharu</creatorcontrib><creatorcontrib>Watanabe, Toyohiko</creatorcontrib><creatorcontrib>Nasu, Yoshitsugu</creatorcontrib><creatorcontrib>Tsugawa, Masaya</creatorcontrib><creatorcontrib>Nasu, Yasutomo</creatorcontrib><creatorcontrib>Wada, Koichiro</creatorcontrib><title>A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial</title><title>Acta medica Okayama</title><addtitle>Acta Med Okayama</addtitle><description>The aim of this report is to introduce an on-going, multicenter, randomized controlled trial to evaluate whether tailored antimicrobial prophylaxis guided by rectal culture screening prevents acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Patients will be randomized into an intervention or non-intervention group; tazobactam-piperacillin or levofloxacin will be prophylactically administered according to the results of rectal culture prior to TRPB in the intervention group whereas levofloxacin will be routinely given in the non-intervention group. The primary endpoint is the occurrence rate of acute bacterial prostatitis after TRPB. Recruitment begins in April, 2021 and the target total sample size is 5,100 participants.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial Infections - diagnosis</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - microbiology</subject><subject>Humans</subject><subject>Male</subject><subject>Multicenter Studies as Topic</subject><subject>Prostatic Diseases - drug therapy</subject><subject>Prostatic Diseases - microbiology</subject><subject>Prostatic Diseases - pathology</subject><subject>Randomized Controlled Trials as Topic</subject><issn>0386-300X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMFO3DAQhn1oBRR66QNUPnJowLETJ-a2XVFaCQSii9TbamJPwMixF9up2D5gn6teCpeZkeb_5h_9hHyq2UndKy5PYQqnknc9f0cOmOhlJRj7tU8-pPTIGG-UZHtkXzQdE6zlB-Tvgi6d9VaDo6toSz3_DW6GbP09zQ9I7xKOs_OYEg0jXYF1IaKhC5_tZHUMw465iWHzsHXwbFMBdugt6gyu0rPLc0T6U0dEv1tcobFQABsizaF4gk_xRby7kjJkpF9t2KTtGV3Qq8JbjT5j_EJvwZsw2T_Ffhl8jsG5Mr58fUTej-ASfnzth-Tu2_lq-b26vL74sVxcVo-iaXMlm65muqtVL7BjuldmaAxv0XAjBiZwRK2h6fu64UYyqRgMDEtW0oACZkZxSI7_393E8DRjyuvJJo3OgccwpzVve6lUqxpWpJ9fpfMwoVlvop0gbtdv2Yt_qUqINA</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Sadahira, Takuya</creator><creator>Maruyama, Yuki</creator><creator>Hiyama, Yoshiki</creator><creator>Kitano, Hiroyuki</creator><creator>Yamada, Hiroki</creator><creator>Goto, Takayuki</creator><creator>Kondo, Tsubasa</creator><creator>Shigemura, Katsumi</creator><creator>Mitsui, Yosuke</creator><creator>Iwata, Takehiro</creator><creator>Edamura, Kohei</creator><creator>Araki, Motoo</creator><creator>Watanabe, Masami</creator><creator>Takenaka, Tadasu</creator><creator>Teishima, Jun</creator><creator>Miyata, Yasuyoshi</creator><creator>Ishikawa, Kiyohito</creator><creator>Takaoka, Ei-Ichiro</creator><creator>Miyazaki, Jun</creator><creator>Takahashi, Satoshi</creator><creator>Masumori, Naoya</creator><creator>Kiyota, Hiroshi</creator><creator>Fujisawa, Masato</creator><creator>Yamamoto, Shingo</creator><creator>Sakuma, Takafumi</creator><creator>Kusumi, Norihiro</creator><creator>Ichikawa, Takaharu</creator><creator>Watanabe, Toyohiko</creator><creator>Nasu, Yoshitsugu</creator><creator>Tsugawa, Masaya</creator><creator>Nasu, Yasutomo</creator><creator>Wada, Koichiro</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20211001</creationdate><title>A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial</title><author>Sadahira, Takuya ; Maruyama, Yuki ; Hiyama, Yoshiki ; Kitano, Hiroyuki ; Yamada, Hiroki ; Goto, Takayuki ; Kondo, Tsubasa ; Shigemura, Katsumi ; Mitsui, Yosuke ; Iwata, Takehiro ; Edamura, Kohei ; Araki, Motoo ; Watanabe, Masami ; Takenaka, Tadasu ; Teishima, Jun ; Miyata, Yasuyoshi ; Ishikawa, Kiyohito ; Takaoka, Ei-Ichiro ; Miyazaki, Jun ; Takahashi, Satoshi ; Masumori, Naoya ; Kiyota, Hiroshi ; Fujisawa, Masato ; Yamamoto, Shingo ; Sakuma, Takafumi ; Kusumi, Norihiro ; Ichikawa, Takaharu ; Watanabe, Toyohiko ; Nasu, Yoshitsugu ; Tsugawa, Masaya ; Nasu, Yasutomo ; Wada, Koichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j345t-64710c71983e70c89db4d25ed2d3b03efecca488142d60690ab0e4706da9a0df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial Infections - diagnosis</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - microbiology</topic><topic>Humans</topic><topic>Male</topic><topic>Multicenter Studies as Topic</topic><topic>Prostatic Diseases - drug therapy</topic><topic>Prostatic Diseases - microbiology</topic><topic>Prostatic Diseases - pathology</topic><topic>Randomized Controlled Trials as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadahira, Takuya</creatorcontrib><creatorcontrib>Maruyama, Yuki</creatorcontrib><creatorcontrib>Hiyama, Yoshiki</creatorcontrib><creatorcontrib>Kitano, Hiroyuki</creatorcontrib><creatorcontrib>Yamada, Hiroki</creatorcontrib><creatorcontrib>Goto, Takayuki</creatorcontrib><creatorcontrib>Kondo, Tsubasa</creatorcontrib><creatorcontrib>Shigemura, Katsumi</creatorcontrib><creatorcontrib>Mitsui, Yosuke</creatorcontrib><creatorcontrib>Iwata, Takehiro</creatorcontrib><creatorcontrib>Edamura, Kohei</creatorcontrib><creatorcontrib>Araki, Motoo</creatorcontrib><creatorcontrib>Watanabe, Masami</creatorcontrib><creatorcontrib>Takenaka, Tadasu</creatorcontrib><creatorcontrib>Teishima, Jun</creatorcontrib><creatorcontrib>Miyata, Yasuyoshi</creatorcontrib><creatorcontrib>Ishikawa, Kiyohito</creatorcontrib><creatorcontrib>Takaoka, Ei-Ichiro</creatorcontrib><creatorcontrib>Miyazaki, Jun</creatorcontrib><creatorcontrib>Takahashi, Satoshi</creatorcontrib><creatorcontrib>Masumori, Naoya</creatorcontrib><creatorcontrib>Kiyota, Hiroshi</creatorcontrib><creatorcontrib>Fujisawa, Masato</creatorcontrib><creatorcontrib>Yamamoto, Shingo</creatorcontrib><creatorcontrib>Sakuma, Takafumi</creatorcontrib><creatorcontrib>Kusumi, Norihiro</creatorcontrib><creatorcontrib>Ichikawa, Takaharu</creatorcontrib><creatorcontrib>Watanabe, Toyohiko</creatorcontrib><creatorcontrib>Nasu, Yoshitsugu</creatorcontrib><creatorcontrib>Tsugawa, Masaya</creatorcontrib><creatorcontrib>Nasu, Yasutomo</creatorcontrib><creatorcontrib>Wada, Koichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Acta medica Okayama</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadahira, Takuya</au><au>Maruyama, Yuki</au><au>Hiyama, Yoshiki</au><au>Kitano, Hiroyuki</au><au>Yamada, Hiroki</au><au>Goto, Takayuki</au><au>Kondo, Tsubasa</au><au>Shigemura, Katsumi</au><au>Mitsui, Yosuke</au><au>Iwata, Takehiro</au><au>Edamura, Kohei</au><au>Araki, Motoo</au><au>Watanabe, Masami</au><au>Takenaka, Tadasu</au><au>Teishima, Jun</au><au>Miyata, Yasuyoshi</au><au>Ishikawa, Kiyohito</au><au>Takaoka, Ei-Ichiro</au><au>Miyazaki, Jun</au><au>Takahashi, Satoshi</au><au>Masumori, Naoya</au><au>Kiyota, Hiroshi</au><au>Fujisawa, Masato</au><au>Yamamoto, Shingo</au><au>Sakuma, Takafumi</au><au>Kusumi, Norihiro</au><au>Ichikawa, Takaharu</au><au>Watanabe, Toyohiko</au><au>Nasu, Yoshitsugu</au><au>Tsugawa, Masaya</au><au>Nasu, Yasutomo</au><au>Wada, Koichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial</atitle><jtitle>Acta medica Okayama</jtitle><addtitle>Acta Med Okayama</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>75</volume><issue>5</issue><spage>663</spage><epage>667</epage><pages>663-667</pages><issn>0386-300X</issn><abstract>The aim of this report is to introduce an on-going, multicenter, randomized controlled trial to evaluate whether tailored antimicrobial prophylaxis guided by rectal culture screening prevents acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Patients will be randomized into an intervention or non-intervention group; tazobactam-piperacillin or levofloxacin will be prophylactically administered according to the results of rectal culture prior to TRPB in the intervention group whereas levofloxacin will be routinely given in the non-intervention group. The primary endpoint is the occurrence rate of acute bacterial prostatitis after TRPB. Recruitment begins in April, 2021 and the target total sample size is 5,100 participants.</abstract><cop>Japan</cop><pmid>34703052</pmid><doi>10.18926/amo/62782</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0386-300X
ispartof Acta medica Okayama, 2021-10, Vol.75 (5), p.663-667
issn 0386-300X
language eng
recordid cdi_proquest_miscellaneous_2586995940
source MEDLINE; Open Access Titles of Japan; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Anti-Bacterial Agents - therapeutic use
Bacterial Infections - diagnosis
Bacterial Infections - drug therapy
Bacterial Infections - microbiology
Humans
Male
Multicenter Studies as Topic
Prostatic Diseases - drug therapy
Prostatic Diseases - microbiology
Prostatic Diseases - pathology
Randomized Controlled Trials as Topic
title A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A18%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Clinical%20Trial%20Evaluating%20the%20Usefulness%20of%20Tailored%20Antimicrobial%20Prophylaxis%20Using%20Rectal-culture%20Screening%20Media%20Prior%20to%20Transrectal%20Prostate%20Biopsy:%20A%20Multicenter,%20Randomized%20Controlled%20Trial&rft.jtitle=Acta%20medica%20Okayama&rft.au=Sadahira,%20Takuya&rft.date=2021-10-01&rft.volume=75&rft.issue=5&rft.spage=663&rft.epage=667&rft.pages=663-667&rft.issn=0386-300X&rft_id=info:doi/10.18926/amo/62782&rft_dat=%3Cproquest_pubme%3E2586995940%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2586995940&rft_id=info:pmid/34703052&rfr_iscdi=true